Biotech entity
All 1 tracked stories fall under one category: pharma. Of the tracked stories, 1 of 1 also mention ABC News, the most common co-covered peer. Each carries 2 original sources on average. We currently track 1 Biotech story that mention The Washington Post, all published on July 29, 2026.
Last mentioned: Aug 24, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: pharma. Of the tracked stories, 1 of 1 also mention ABC News, the most common co-covered peer. Each carries 2 original sources on average. We currently track 1 Biotech story that mention The Washington Post, all published on July 29, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 3 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering The Washington Post. Shared-story counts are live from our verified record — not editorial picks.
The termination of the $3.6 billion Part D premium subsidy could alter prescription utilization patterns for 25 million Medicare beneficiaries, potentially reducing demand for branded drugs and pressuring pharma companies reliant on Part D volume.
Source: kprcradio.iheart.com · channel963.iheart.com
The Washington Post is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
